CN104740071B - A kind of pharmaceutical composition for the treatment of fracture - Google Patents

A kind of pharmaceutical composition for the treatment of fracture Download PDF

Info

Publication number
CN104740071B
CN104740071B CN201510205271.5A CN201510205271A CN104740071B CN 104740071 B CN104740071 B CN 104740071B CN 201510205271 A CN201510205271 A CN 201510205271A CN 104740071 B CN104740071 B CN 104740071B
Authority
CN
China
Prior art keywords
parts
fracture
folium
treatment
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510205271.5A
Other languages
Chinese (zh)
Other versions
CN104740071A (en
Inventor
祝海滨
潘德利
范海燕
邹先政
赵松强
赵鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhu Haibin
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510205271.5A priority Critical patent/CN104740071B/en
Publication of CN104740071A publication Critical patent/CN104740071A/en
Application granted granted Critical
Publication of CN104740071B publication Critical patent/CN104740071B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of pharmaceutical composition for the treatment of fracture, it is made up by weight of following bulk drugs: sago cycas spend 480 parts, youth-and-old-age 450 parts, Ramulus et Folium Debregeasiae Edulis 420 parts, Flos Ixorae Chinensis (Cacumen et Folium Clerodendri paniculati) 350 parts, Herba Blumeae clarkei 320 parts, dawrf mallow root 300 parts, rabbit hair Artemisia 280 parts, blue or green 250 parts of straw sandals, Lombardy poplar 220 parts, Radix seu folium abelmoschi moschati 200 parts and Herba bidentis parviflorae 180 parts.The pharmaceutical composition for the treatment of fracture of the present invention uses natural drug, and therefore it has instant effect, good effect, the advantage that has no side effect.

Description

A kind of pharmaceutical composition for the treatment of fracture
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of pharmaceutical composition for the treatment of fracture.
Background technology
Fracture refers to a kind of disease because the reason such as wound or pathology causes bone parts or ruptures completely.Its main clinical manifestation is: fractures has localized pain and tenderness, local swelling and occur ecchymosis, and limb function is partially or completely lost, and completeness sclerotin still can occur cacomelia and abnormal movement.The existing bone injury Chinese medicine for oral administration that is used for the treatment of generally adopts traumatic injury class Chinese patent medicine, as pill for traumatic injuries, bone-knitting capsule etc., these medicines only play assosting effect in clinical therapeutic efficacy, effective bone-setting treatment cannot be realized at short notice, make patient that medicine cannot be relied at short notice to get well to realize bone injury recovery from illness.
Summary of the invention
The object of this invention is to provide a kind of pharmaceutical composition for the treatment of fracture.
In order to realize object of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of fracture, it is made up by weight of following bulk drugs: sago cycas spend 480 parts, youth-and-old-age 450 parts, Ramulus et Folium Debregeasiae Edulis 420 parts, Flos Ixorae Chinensis (Cacumen et Folium Clerodendri paniculati) 350 parts, Herba Blumeae clarkei 320 parts, dawrf mallow root 300 parts, rabbit hair Artemisia 280 parts, blue or green 250 parts of straw sandals, Lombardy poplar 220 parts, Radix seu folium abelmoschi moschati 200 parts and Herba bidentis parviflorae 180 parts.
Preferably, described pharmaceutical composition can be tablet, dispersible tablet, ointment or suppository.
The present invention also provides the application of compositions in the medicine of preparation treatment fracture, and described medicine is made up by weight of following bulk drugs: sago cycas spend 480 parts, youth-and-old-age 450 parts, Ramulus et Folium Debregeasiae Edulis 420 parts, Flos Ixorae Chinensis (Cacumen et Folium Clerodendri paniculati) 350 parts, Herba Blumeae clarkei 320 parts, dawrf mallow root 300 parts, rabbit hair Artemisia 280 parts, blue or green 250 parts of straw sandals, Lombardy poplar 220 parts, Radix seu folium abelmoschi moschati 200 parts and Herba bidentis parviflorae 180 parts.
In the present compositions, sago cycas flower, youth-and-old-age are monarch drug, and Ramulus et Folium Debregeasiae Edulis, Flos Ixorae Chinensis (Cacumen et Folium Clerodendri paniculati), Herba Blumeae clarkei are ministerial drug, and dawrf mallow root, rabbit hair Artemisia, straw sandals green grass or young crops, Lombardy poplar, Radix seu folium abelmoschi moschati are adjuvant drug, and Herba bidentis parviflorae is for making medicine.
Use natural drug in the pharmaceutical composition for the treatment of fracture of the present invention, therefore it has instant effect, good effect, the advantage that has no side effect.
Detailed description of the invention
Below by way of the description of detailed description of the invention, the invention will be further described, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, various amendment or improvement can be made, but only otherwise depart from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment powder of the present invention
Get sago cycas spend 480 grams, youth-and-old-age 450 grams, Ramulus et Folium Debregeasiae Edulis 420 grams, Flos Ixorae Chinensis (Cacumen et Folium Clerodendri paniculati) 350 grams, Herba Blumeae clarkei 320 grams, dawrf mallow root 300 grams, rabbit hair Artemisia 280 grams, blue or green 250 grams of straw sandals, Lombardy poplar 220 grams, Radix seu folium abelmoschi moschati 200 grams and Herba bidentis parviflorae 180 grams, pulverize, cross 100 mesh sieves, then sucrose 800 grams is added, mixing, in loading 300 bags and get final product.
Experimental example
Standards of Chinese Medical Syndrome Differentiation
According to " Chinese medical disease Standardization of diagnosis and curative effect " (State Administration of Traditional Chinese Medicine. [S]. Nanjing: publishing house of Nanjing University; 1994:94) formulate: pain appears in all traumatic injury; swelling, bony crepitus, abnormal movement; limb activity is limited; the dermal ecchymosis, dimly red tongue or have trace speckle, tongue is white; wiry and frequent pulse, belongs to syndrome of qi stagnation and blood stasis person.And make a definite diagnosis through x-ray inspection.Get rid of pathologisch Bruch.
Selector close state diagnostic criteria patient 130 example, wherein man 70 example, female 60 example.Age is 22-43 year, average 35 years old.Course of disease 1-7d.
The powder prepared in embodiment is used to treat, every day 2 times, oral 1 bag at every turn, treatment 2 months continuously.At treatments period, the fracture site of patient is adopted Boards wall, and exhort that patient moves less.
Curative effect determinate standard
Draft with reference to " Chinese medical disease Standardization of diagnosis and curative effect " (State Administration of Traditional Chinese Medicine. Chinese medical disease Standardization of diagnosis and curative effect [S]. Nanjing: publishing house of Nanjing University, 1994:94).
1, cure: union of fracture, joint motion freely;
2, effective: the healing of fracture major part, function of joint is improved;
3, invalid: fracture does not connect, and without growth of spur, ankylosis, function is poor.
Result
Through treatment, find the union of fracture of all patients, joint motion freely, therefore all meets the curative effect determinate standard of healing.And do not find obvious untoward reaction over the course for the treatment of.

Claims (1)

1. treat the pharmaceutical composition of fracture for one kind, it is characterized in that, it is made up by weight of following bulk drugs: sago cycas spend 480 parts, youth-and-old-age 450 parts, Ramulus et Folium Debregeasiae Edulis 420 parts, Flos Ixorae Chinensis (Cacumen et Folium Clerodendri paniculati) 350 parts, Herba Blumeae clarkei 320 parts, dawrf mallow root 300 parts, rabbit hair Artemisia 280 parts, blue or green 250 parts of straw sandals, Lombardy poplar 220 parts, Radix seu folium abelmoschi moschati 200 parts and Herba bidentis parviflorae 180 parts.
CN201510205271.5A 2015-04-28 2015-04-28 A kind of pharmaceutical composition for the treatment of fracture Expired - Fee Related CN104740071B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510205271.5A CN104740071B (en) 2015-04-28 2015-04-28 A kind of pharmaceutical composition for the treatment of fracture

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510205271.5A CN104740071B (en) 2015-04-28 2015-04-28 A kind of pharmaceutical composition for the treatment of fracture

Publications (2)

Publication Number Publication Date
CN104740071A CN104740071A (en) 2015-07-01
CN104740071B true CN104740071B (en) 2015-10-14

Family

ID=53580693

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510205271.5A Expired - Fee Related CN104740071B (en) 2015-04-28 2015-04-28 A kind of pharmaceutical composition for the treatment of fracture

Country Status (1)

Country Link
CN (1) CN104740071B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127856A (en) * 2014-08-19 2014-11-05 苏茂顺 Medicine used for treating knee osteoarthritis pain in anesthesia department and preparation method thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104127856A (en) * 2014-08-19 2014-11-05 苏茂顺 Medicine used for treating knee osteoarthritis pain in anesthesia department and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中医药治疗骨折迟缓愈合43例;吕忠文;《中国中医药信息杂志》;20040930;第11卷(第09期);第808页第1栏第4段 *
蓝钢,蓝世隆.民族中草药治疗开放性骨折感染疗效观察.《中医正骨》.1994,第06卷(第04期), *

Also Published As

Publication number Publication date
CN104740071A (en) 2015-07-01

Similar Documents

Publication Publication Date Title
CN103223153B (en) Medicament for treating femoral head necrosis
CN102872238A (en) Medicine for treating osteoarthrosis and preparation method thereof
CN103356980B (en) Medicament for treating afterpains
CN104740071B (en) A kind of pharmaceutical composition for the treatment of fracture
CN102139051A (en) Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia
CN104940291A (en) Composition for preventing and treating honeybee microsporidiosis and use thereof
CN103585457B (en) A kind of medicament for the treatment of fracture
CN103599213B (en) Medicinal composition for treating bone fracture and preparation method thereof
CN103432506B (en) Pharmaceutical composition for treating upper respiratory infection
CN101322764B (en) External use medicament for treating hyperosteogeny of cervical vertebra and lumbar principally and preparation thereof
CN101077360B (en) Medicinal composition for treating sugar diabetes skin ulcer and preparation method thereof
CN101249236B (en) Chinese and western medicine combined preparations for curing epileptic
CN103893732B (en) A kind of Tibetan medicine treating chronic gastritis
CN102671076B (en) Medicament for treating gout
CN102240330B (en) Medicinal composition for strengthening bones
CN101843759B (en) Oral Chinese medicament for treating fracture
CN104771560B (en) A kind of medicine for the treatment of mania
CN103157085A (en) Drug for treating fracture
CN105055844A (en) Traditional Chinese medicine preparation for treating chronic constipation
CN103585500B (en) A kind of medicament for the treatment of diarrhoea
CN105288325A (en) Traditional Chinese medicine for treating arrhythmia caused by deficiency of both vital energy and yin
CN104840624A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN103784742A (en) Medicinal preparation for treating chronic lumbar strain
CN101843799B (en) Oral Chinese medicament for treating fracture
CN103041349B (en) Decoction for treating femoral head necrosis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: ZHU HAIBIN

Free format text: FORMER OWNER: WANG AILING

Effective date: 20150909

C41 Transfer of patent application or patent right or utility model
C53 Correction of patent for invention or patent application
CB03 Change of inventor or designer information

Inventor after: Zhu Haibin

Inventor after: Pan Deli

Inventor after: Fan Haiyan

Inventor after: Zou Xianzheng

Inventor after: Zhao Songqiang

Inventor after: Zhao Peng

Inventor before: Wang Ailing

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: WANG AILING TO: ZHU HAIBIN PAN DELI FAN HAIYAN ZOU XIANZHENG ZHAO SONGQIANG ZHAO PENG

TA01 Transfer of patent application right

Effective date of registration: 20150909

Address after: 266599 Hainan Island Road, Huangdao District, Shandong, No. 158, No.

Applicant after: Zhu Haibin

Address before: 054000, No. 9, middle street, Luo Luo Road, Xingtai County, Xingtai, Hebei

Applicant before: Wang Ailing

C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151014

Termination date: 20160428